[Cellular immunity and the results of 2-year immunosuppressive treatment combined with the administration of dipyridamole and indomethacin in patients with chronic glomerulonephritis].
Kacprzyk
F
F
Orłowski
Z
Z
D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D002908:Chronic Disease; D004176:Dipyridamole / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007213:Indomethacin / Q000008:administration & dosage*; D008875:Middle Aged; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013997:Time Factors
D007166:Immunosuppressive Agents; D004176:Dipyridamole; D007213:Indomethacin
Odporność komórkowa a wyniki dwuletniego leczenia immunosupresyjnego połaczonego ze stosowaniem dipyridamolu i indometacyny u chorych na przewlekłe kłebkowe zapalenie nerek.